BindingDB logo
myBDB logout
Compile Data Set for Download or QSAR

Found 4 hits of ic50 for monomerid = 98027   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kJ/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Hepatocyte growth factor receptor


(Homo sapiens (Human))
BDBM98027
PNG
(US10472367, Compound Formula I | US10919901, Compo...)
Show SMILES C[C@@H](O)CNC(=O)c1ccc(cc1F)-c1cnc2ncc(Cc3ccc4ncccc4c3)n2n1 |r|
Show InChI InChI=1S/C25H21FN6O2/c1-15(33)12-28-24(34)20-6-5-18(11-21(20)26)23-14-30-25-29-13-19(32(25)31-23)10-16-4-7-22-17(9-16)3-2-8-27-22/h2-9,11,13-15,33H,10,12H2,1H3,(H,28,34)/t15-/m1/s1
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 0.550n/an/an/an/a7.530



Incyte Corporation

US Patent


Assay Description
The compounds of the intervention were screened in vitro for their ability to inhibit c-Met kinase activity.


US Patent US8487096 (2013)


BindingDB Entry DOI: 10.7270/Q2319THZ
More data for this
Ligand-Target Pair
Hepatocyte growth factor receptor


(Homo sapiens (Human))
BDBM98027
PNG
(US10472367, Compound Formula I | US10919901, Compo...)
Show SMILES C[C@@H](O)CNC(=O)c1ccc(cc1F)-c1cnc2ncc(Cc3ccc4ncccc4c3)n2n1 |r|
Show InChI InChI=1S/C25H21FN6O2/c1-15(33)12-28-24(34)20-6-5-18(11-21(20)26)23-14-30-25-29-13-19(32(25)31-23)10-16-4-7-22-17(9-16)3-2-8-27-22/h2-9,11,13-15,33H,10,12H2,1H3,(H,28,34)/t15-/m1/s1
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 0.550n/an/an/an/an/an/a



Incyte Holdings Corporation; Incyte Corporation

US Patent


Assay Description
The compounds of the invention were screened in vitro for their ability to inhibit c-Met kinase activity. The IC50 values for the inhibition of c-Met...


US Patent US10919901 (2021)


BindingDB Entry DOI: 10.7270/Q2B85C72
More data for this
Ligand-Target Pair
Hepatocyte growth factor receptor


(Homo sapiens (Human))
BDBM98027
PNG
(US10472367, Compound Formula I | US10919901, Compo...)
Show SMILES C[C@@H](O)CNC(=O)c1ccc(cc1F)-c1cnc2ncc(Cc3ccc4ncccc4c3)n2n1 |r|
Show InChI InChI=1S/C25H21FN6O2/c1-15(33)12-28-24(34)20-6-5-18(11-21(20)26)23-14-30-25-29-13-19(32(25)31-23)10-16-4-7-22-17(9-16)3-2-8-27-22/h2-9,11,13-15,33H,10,12H2,1H3,(H,28,34)/t15-/m1/s1
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 0.550n/an/an/an/an/an/a



INCYTE INCORPORATION; INCYTE HOLDINGS CORPORATION

US Patent


Assay Description
The compounds of the invention were screened in vitro for their ability to inhibit c-Met kinase activity. Briefly, histidine-tagged c-Met catalytic d...


US Patent US10472367 (2019)


BindingDB Entry DOI: 10.7270/Q2639S3S
More data for this
Ligand-Target Pair
Hepatocyte growth factor receptor


(Homo sapiens (Human))
BDBM98027
PNG
(US10472367, Compound Formula I | US10919901, Compo...)
Show SMILES C[C@@H](O)CNC(=O)c1ccc(cc1F)-c1cnc2ncc(Cc3ccc4ncccc4c3)n2n1 |r|
Show InChI InChI=1S/C25H21FN6O2/c1-15(33)12-28-24(34)20-6-5-18(11-21(20)26)23-14-30-25-29-13-19(32(25)31-23)10-16-4-7-22-17(9-16)3-2-8-27-22/h2-9,11,13-15,33H,10,12H2,1H3,(H,28,34)/t15-/m1/s1
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 0.550n/an/an/an/a7.530



Incyte Holdings Corporation; Incyte Corporation

US Patent


Assay Description
The compounds of the invention were screened in vitro for their ability to inhibit c-Met kinase activity. The IC50 values for the inhibition of c-M...


US Patent US9221824 (2015)


BindingDB Entry DOI: 10.7270/Q2MP524M
More data for this
Ligand-Target Pair